Showing 67,781 - 67,800 results of 108,461 for search '(( 5 ((026 decrease) OR (a decrease)) ) OR ( a ((nn decrease) OR (point decrease)) ))', query time: 1.27s Refine Results
  1. 67781
  2. 67782
  3. 67783

    Table_2_Sleep Disorders in Leucine-Rich Glioma-Inactivated Protein 1 and Contactin Protein-Like 2 Antibody-Associated Diseases.DOCX by Nan Lin (26755)

    Published 2020
    “…Twenty-one PSG recordings from patients with LGI1-Ab encephalitis demonstrated a decrease in total sleep time (TST) (median 365.5, range 184.5–495.5 min), sleep efficiency (70.0%, 47–92%), N3 sleep (9.7%, 0–32.9%), and REM sleep (9.9%, 0.4–27.9%). …”
  4. 67784

    Table_1_Sleep Disorders in Leucine-Rich Glioma-Inactivated Protein 1 and Contactin Protein-Like 2 Antibody-Associated Diseases.DOCX by Nan Lin (26755)

    Published 2020
    “…Twenty-one PSG recordings from patients with LGI1-Ab encephalitis demonstrated a decrease in total sleep time (TST) (median 365.5, range 184.5–495.5 min), sleep efficiency (70.0%, 47–92%), N3 sleep (9.7%, 0–32.9%), and REM sleep (9.9%, 0.4–27.9%). …”
  5. 67785

    Table_2_Sleep Disorders in Leucine-Rich Glioma-Inactivated Protein 1 and Contactin Protein-Like 2 Antibody-Associated Diseases.DOCX by Nan Lin (26755)

    Published 2020
    “…Twenty-one PSG recordings from patients with LGI1-Ab encephalitis demonstrated a decrease in total sleep time (TST) (median 365.5, range 184.5–495.5 min), sleep efficiency (70.0%, 47–92%), N3 sleep (9.7%, 0–32.9%), and REM sleep (9.9%, 0.4–27.9%). …”
  6. 67786

    Table_1_Sleep Disorders in Leucine-Rich Glioma-Inactivated Protein 1 and Contactin Protein-Like 2 Antibody-Associated Diseases.DOCX by Nan Lin (26755)

    Published 2020
    “…Twenty-one PSG recordings from patients with LGI1-Ab encephalitis demonstrated a decrease in total sleep time (TST) (median 365.5, range 184.5–495.5 min), sleep efficiency (70.0%, 47–92%), N3 sleep (9.7%, 0–32.9%), and REM sleep (9.9%, 0.4–27.9%). …”
  7. 67787

    Temporal Trend in Young-Onset Type 2 Diabetes - the Macrovascular and Mortality Risk: Study of UK Primary Care Electronic Medical Records by Digsu N. Koye (8881108)

    Published 2020
    “…The incidence rates of ASCVD and ACM declined in people aged ≥50 years, but did not decrease in people <50 years. Compared to people aged ≥50 years, those aged 18-39 years at diagnosis had higher obesity (71% obese), higher HbA1c (8.6%), 71% had high LDL-C, while only 18% were on cardio-protective therapy. …”
  8. 67788

    Plasma membrane vesicles (ROV) of cancer cells can produce ATP and PP<sub>i</sub> with acid gradient. by Gautam Dhar (723875)

    Published 2015
    “…Lane 1, untreated sample; lane 2, phosphatase (P-ase): PP<sub>i</sub> band decreased; lane 3, pyrophosphatase (PP<sub>i</sub>-ase): PP<sub>i</sub> band decreased; lane 4, nicotinamide mononucleotide adenylyl transferase 1 (NMNAT1) and excess NAD: PP<sub>i</sub> band decreased and ATP band appeared; lane 5, untreated sample; lane 6, ATP sulphurylase and excess Adenosine-5’- phosphosulphate (APS): PP<sub>i</sub> band decreased and ATP band appeared. …”
  9. 67789

    Kinetics of T3 target genes expression in wild-type and <i>TRα<sup>AMI</sup>/S</i> mice in the cerebellum as measured by Q-RT-PCR. by Fabrice Chatonnet (37037)

    Published 2012
    “…<p>Expression levels were calculated for each target gene by Q-RT-PCR in wild-type and <i>TRα<sup>AMI</sup>/S</i> littermates at P4, P8, P15 and P21 (minimum 3 animals of each genotype for each time point). Data are expressed as mean ± SD using wild-type P4 values (A), for genes with decreasing or stable expression levels over time or P21 (B), for genes with increasing expression levels, as a reference for each genotype. …”
  10. 67790

    Zerumbone induced caspase activation subsequent to mitochondrial transmembrane potential loss. by Praveen K. Sobhan (220116)

    Published 2013
    “…Imaging for Hoechst, TMRM, ECFP, and EYFP FRET were carried out using a 96 well plate Bio-imager as described at the indicated time points. …”
  11. 67791

    Cellular characteristics of <i>M</i>. <i>commoda</i> during short-exposure light shift experiments and qPCR analysis of three genes. by Marie L. Cuvelier (3825829)

    Published 2017
    “…Values >1 increased relative to the T<sub>0</sub> control, while those <1 decreased. Note differences in y-axis scales. Samples that were significantly different (<i>p</i><0.01) from the control (*) and HL+UV samples that were significantly different from HL at the same time point (^) are denoted. …”
  12. 67792

    Cold pressor, 4 group. by Paul M. Macey (316393)

    Published 2014
    “…For females (<b>B</b>) and males (<b>C</b>), changes in BOLD signals relative to baseline (group mean ± SE), with time-points of significant increase or decrease relative to baseline within-group, and time-points of between-group differences (RMANOVA, <i>p</i><0.05).…”
  13. 67793

    Model architecture and dynamics. by Kai Ueltzhöffer (754206)

    Published 2015
    “…Due to the symmetry of the system, these directions form the corners of a symmetrical tetrahedron. (F) Threshold independence of decision module: Shown are the projections of a single three-dimensional decision process onto the four directions corresponding to the increase of a single selective population and the simultaneous decrease in all others. …”
  14. 67794

    Tobacco control in the Eastern Mediterranean region: implementation progress and persisting challenges by Abu-Rmeileh, Niveen M E

    Published 2022
    “…Tobacco use is the leading cause of preventable mortality worldwide, projected to claim 1 billion lives in the twenty-first century.1 Tobacco prevalence rates are expected to decrease across all the WHO regions by 2025 as a result of tobacco control efforts. …”
    Get full text
    Get full text
  15. 67795

    Concomitant experimental coinfection by Plasmodium berghei NK65-NY and Ascaris suum downregulates the Ascaris-specific immune response and potentiates Ascaris-associated lung patho... by Flaviane Vieira-Santos (8357704)

    Published 2020
    “…The concentrations of interleukin (IL)-1β, IL-12/IL-23p40, IL-6, IL-4, IL-33, IL-13, IL-5, IL-10, IL-17A, IFN-γ, TNF-α and TGF-β were assayed by sandwich ELISA. …”
  16. 67796

    Data_Sheet_4_Omeprazole Increases the Efficacy of Acyclovir Against Herpes Simplex Virus Type 1 and 2.PDF by Martin Michaelis (23843)

    Published 2019
    “…Omeprazole 80 μg/mL caused a 10.8-fold (Vero cells) and 47.7-fold (HaCaT cells) decrease of the acyclovir concentrations that reduced HSV-1-induced CPE formation by 50% (IC<sub>50</sub>). …”
  17. 67797

    Effect of De-intensifying Diabetes Medications on Negative Events in Older Veteran Nursing Home Residents by Joshua D. Niznik (12480320)

    Published 2022
    “…Diabetes treatment de-intensification (dose decrease or discontinuation of a non-insulin agent or stopping insulin sustained ≥7 days) was identified within 30 days following HbA1c measurement. …”
  18. 67798

    Untargeted Urinary Proteomics Uncovers Nephroprotective and Systemic Adaptations after Obesity Surgery-Induced Weight Loss by Pedro R. Pereira (6016460)

    Published 2025
    “…A decrease in inflammation protein markers (α-1-acid glycoproteins), alongside an increase in proteins associated with immune modulation and oxidative stress protection (dipeptidase 1, heat shock cognate 71 kDa protein) were observed. …”
  19. 67799

    Data_Sheet_2_Omeprazole Increases the Efficacy of Acyclovir Against Herpes Simplex Virus Type 1 and 2.PDF by Martin Michaelis (23843)

    Published 2019
    “…Omeprazole 80 μg/mL caused a 10.8-fold (Vero cells) and 47.7-fold (HaCaT cells) decrease of the acyclovir concentrations that reduced HSV-1-induced CPE formation by 50% (IC<sub>50</sub>). …”
  20. 67800

    Data_Sheet_1_Omeprazole Increases the Efficacy of Acyclovir Against Herpes Simplex Virus Type 1 and 2.PDF by Martin Michaelis (23843)

    Published 2019
    “…Omeprazole 80 μg/mL caused a 10.8-fold (Vero cells) and 47.7-fold (HaCaT cells) decrease of the acyclovir concentrations that reduced HSV-1-induced CPE formation by 50% (IC<sub>50</sub>). …”